S&P 500   3,449.00 (+0.64%)
DOW   28,370.75 (+0.62%)
QQQ   284.98 (+0.42%)
AAPL   116.18 (+0.17%)
MSFT   215.48 (+0.59%)
FB   264.12 (+1.04%)
GOOGL   1,543.57 (+0.89%)
AMZN   3,202.68 (-0.14%)
TSLA   421.00 (-2.28%)
NVDA   542.79 (+0.53%)
BABA   308.56 (+1.07%)
CGC   18.85 (-4.85%)
GE   7.34 (+0.69%)
MU   53.01 (+0.72%)
AMD   81.49 (-0.62%)
T   26.98 (+0.37%)
F   7.74 (+1.98%)
ACB   4.37 (-7.22%)
GILD   60.33 (-0.40%)
NFLX   523.73 (-1.32%)
BA   167.65 (+0.32%)
BAC   24.02 (+1.26%)
DIS   124.94 (+0.57%)
S&P 500   3,449.00 (+0.64%)
DOW   28,370.75 (+0.62%)
QQQ   284.98 (+0.42%)
AAPL   116.18 (+0.17%)
MSFT   215.48 (+0.59%)
FB   264.12 (+1.04%)
GOOGL   1,543.57 (+0.89%)
AMZN   3,202.68 (-0.14%)
TSLA   421.00 (-2.28%)
NVDA   542.79 (+0.53%)
BABA   308.56 (+1.07%)
CGC   18.85 (-4.85%)
GE   7.34 (+0.69%)
MU   53.01 (+0.72%)
AMD   81.49 (-0.62%)
T   26.98 (+0.37%)
F   7.74 (+1.98%)
ACB   4.37 (-7.22%)
GILD   60.33 (-0.40%)
NFLX   523.73 (-1.32%)
BA   167.65 (+0.32%)
BAC   24.02 (+1.26%)
DIS   124.94 (+0.57%)
S&P 500   3,449.00 (+0.64%)
DOW   28,370.75 (+0.62%)
QQQ   284.98 (+0.42%)
AAPL   116.18 (+0.17%)
MSFT   215.48 (+0.59%)
FB   264.12 (+1.04%)
GOOGL   1,543.57 (+0.89%)
AMZN   3,202.68 (-0.14%)
TSLA   421.00 (-2.28%)
NVDA   542.79 (+0.53%)
BABA   308.56 (+1.07%)
CGC   18.85 (-4.85%)
GE   7.34 (+0.69%)
MU   53.01 (+0.72%)
AMD   81.49 (-0.62%)
T   26.98 (+0.37%)
F   7.74 (+1.98%)
ACB   4.37 (-7.22%)
GILD   60.33 (-0.40%)
NFLX   523.73 (-1.32%)
BA   167.65 (+0.32%)
BAC   24.02 (+1.26%)
DIS   124.94 (+0.57%)
S&P 500   3,449.00 (+0.64%)
DOW   28,370.75 (+0.62%)
QQQ   284.98 (+0.42%)
AAPL   116.18 (+0.17%)
MSFT   215.48 (+0.59%)
FB   264.12 (+1.04%)
GOOGL   1,543.57 (+0.89%)
AMZN   3,202.68 (-0.14%)
TSLA   421.00 (-2.28%)
NVDA   542.79 (+0.53%)
BABA   308.56 (+1.07%)
CGC   18.85 (-4.85%)
GE   7.34 (+0.69%)
MU   53.01 (+0.72%)
AMD   81.49 (-0.62%)
T   26.98 (+0.37%)
F   7.74 (+1.98%)
ACB   4.37 (-7.22%)
GILD   60.33 (-0.40%)
NFLX   523.73 (-1.32%)
BA   167.65 (+0.32%)
BAC   24.02 (+1.26%)
DIS   124.94 (+0.57%)
Log in
OTCMKTS:GLAPY

Glanbia Stock Forecast, Price & News

$52.98
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$52.98
Now: $52.98
$52.98
50-Day Range
$51.00
MA: $54.18
$60.00
52-Week Range
$45.48
Now: $52.98
$63.00
VolumeN/A
Average Volume1,626 shs
Market Capitalization$3.14 billion
P/E Ratio10.75
Dividend Yield2.27%
Beta0.19
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, the Internet, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment operates as a milk processor in Ireland; and produces a range of value added dairy ingredients and consumer products. It also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, BSN, Isopure, Nutramino, ABB, thinkThin, Amazing Grass, Body & Fit, and SlimFast brands in approximately 100 countries. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More
Glanbia logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 2.5Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.32 out of 5 stars

Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
Current SymbolOTCMKTS:GLAPY
CUSIPN/A
CIKN/A
Phone353-56-777-2200
Employees7,385

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.34 billion
Cash Flow$7.14 per share
Book Value$32.19 per share

Profitability

Miscellaneous

Market Cap$3.14 billion
Next Earnings DateN/A
OptionableNot Optionable
$52.98
0.00 (0.00 %)
(As of 10/19/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GLAPY News and Ratings via Email

Sign-up to receive the latest news and ratings for GLAPY and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Glanbia (OTCMKTS:GLAPY) Frequently Asked Questions

How has Glanbia's stock been impacted by Coronavirus?

Glanbia's stock was trading at $57.58 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, GLAPY shares have decreased by 8.0% and is now trading at $52.98.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Glanbia?

Glanbia saw a increase in short interest in the month of September. As of September 30th, there was short interest totaling 400 shares, an increase of 33.3% from the September 15th total of 300 shares. Based on an average daily trading volume, of 900 shares, the short-interest ratio is currently 0.4 days.
View Glanbia's Short Interest
.

Who are some of Glanbia's key competitors?

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 55)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 55)
  • Mr. Brian Phelan, Exec. Director & CEO of Glanbia Nutritionals (Age 52)
  • Mr. Hugh McGuire, Exec. Director & CEO of Glanbia Performance Nutrition (Age 48)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPY."

How do I buy shares of Glanbia?

Shares of GLAPY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Glanbia's stock price today?

One share of GLAPY stock can currently be purchased for approximately $52.98.

How big of a company is Glanbia?

Glanbia has a market capitalization of $3.14 billion and generates $4.34 billion in revenue each year. The company earns $201.82 million in net income (profit) each year or $4.93 on an earnings per share basis. Glanbia employs 7,385 workers across the globe.

What is Glanbia's official website?

The official website for Glanbia is www.glanbia.com.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House Ring Road, KILKENNY L2, R95 E866. The company can be reached via phone at 353-56-777-2200 or via email at [email protected]

This page was last updated on 10/20/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.